These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18335974

  • 1. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
    Velaparthi S, Brunsteiner M, Uddin R, Wan B, Franzblau SG, Petukhov PA.
    J Med Chem; 2008 Apr 10; 51(7):1999-2002. PubMed ID: 18335974
    [Abstract] [Full Text] [Related]

  • 2. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G, Devi PB, Nallangi R, Sridevi JP, Saxena S, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1938-47. PubMed ID: 24565972
    [Abstract] [Full Text] [Related]

  • 3. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y, Gao P, Liu Y, Ji X, Gan M, Guan Y, Hao X, Li Z, Xiao C.
    Bioorg Med Chem Lett; 2011 Jul 01; 21(13):3943-6. PubMed ID: 21641210
    [Abstract] [Full Text] [Related]

  • 4. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Devi PB, Nallangi R, Yogeeswari P, Sriram D.
    Eur J Med Chem; 2013 Nov 01; 69():356-64. PubMed ID: 24077526
    [Abstract] [Full Text] [Related]

  • 5. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Aug 01; 22(15):4223-32. PubMed ID: 24953948
    [Abstract] [Full Text] [Related]

  • 6. Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.
    Hung AW, Silvestre HL, Wen S, George GP, Boland J, Blundell TL, Ciulli A, Abell C.
    ChemMedChem; 2016 Jan 05; 11(1):38-42. PubMed ID: 26486566
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
    Fullam E, Talbot J, Abuhammed A, Westwood I, Davies SG, Russell AJ, Sim E.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2759-64. PubMed ID: 23518278
    [Abstract] [Full Text] [Related]

  • 8. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB, Samala G, Sridevi JP, Saxena S, Alvala M, Salina EG, Sriram D, Yogeeswari P.
    ChemMedChem; 2014 Nov 01; 9(11):2538-47. PubMed ID: 25155986
    [Abstract] [Full Text] [Related]

  • 9. Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis.
    Ntie-Kang F, Kannan S, Wichapong K, Owono Owono LC, Sippl W, Megnassan E.
    Mol Biosyst; 2014 Feb 01; 10(2):223-39. PubMed ID: 24240974
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.
    Balaji NV, HariBabu B, Rao VU, Subbaraju GV, Nagasree KP, Kumar MMK.
    Curr Top Med Chem; 2019 Feb 01; 19(9):662-682. PubMed ID: 30834836
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2016 Mar 15; 24(6):1298-307. PubMed ID: 26867485
    [Abstract] [Full Text] [Related]

  • 12. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB, Jogula S, Reddy AP, Saxena S, Sridevi JP, Sriram D, Yogeeswari P.
    Mol Inform; 2015 Feb 15; 34(2-3):147-59. PubMed ID: 27490037
    [Abstract] [Full Text] [Related]

  • 13. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T, Rodriguez F, Saffon N, Mallet-Ladeira S, Gorichko M, de Jesus Lopes Ribeiro AL, Pasca MR, Lherbet C, Voitenko Z, Baltas M.
    Eur J Med Chem; 2013 Feb 15; 70():37-48. PubMed ID: 24140915
    [Abstract] [Full Text] [Related]

  • 14. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ, Samy JG, Jain CB, Dutt KR, Khalilullah H, Nomani MS.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):969-72. PubMed ID: 22197387
    [Abstract] [Full Text] [Related]

  • 15. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E, Novikov M, Babkov D, Ozerov A, Chernousova L, Andreevskaya S, Smirnova T, Karpenko I, Chizhov A, Murthu P, Lutz S, Kochetkov S, Seley-Radtke KL, Khandazhinskaya AL.
    Chem Biol Drug Des; 2015 Dec 15; 86(6):1387-96. PubMed ID: 26061192
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
    Gaikwad NB, Nirmale K, Sahoo SK, Ahmad MN, Kaul G, Shukla M, Nanduri S, Das Gupta A, Chopra S, Yaddanapudi MV.
    Arch Pharm (Weinheim); 2021 May 15; 354(5):e2000349. PubMed ID: 33351199
    [Abstract] [Full Text] [Related]

  • 17. Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis.
    Zhao Y, Bacher A, Illarionov B, Fischer M, Georg G, Ye QZ, Fanwick PE, Franzblau SG, Wan B, Cushman M.
    J Org Chem; 2009 Aug 07; 74(15):5297-303. PubMed ID: 19545132
    [Abstract] [Full Text] [Related]

  • 18. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
    Van Calenbergh S, Pochet S, Munier-Lehmann H.
    Curr Top Med Chem; 2012 Aug 07; 12(7):694-705. PubMed ID: 22283813
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and characterization of dual inhibitors against new targets FabG4 and HtdX of Mycobacterium tuberculosis.
    Banerjee DR, Biswas R, Das AK, Basak A.
    Eur J Med Chem; 2015 Jul 15; 100():223-34. PubMed ID: 26092447
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD+) synthetase inhibitors as potential antitubercular agents.
    Wang X, Ahn YM, Lentscher AG, Lister JS, Brothers RC, Kneen MM, Gerratana B, Boshoff HI, Dowd CS.
    Bioorg Med Chem Lett; 2017 Sep 15; 27(18):4426-4430. PubMed ID: 28827112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.